PROGRAF 5 mg capsule

DRUG2 trials

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Centre Hospitalier Universitaire De Nantes

Conditions

Early graft dysfunction after heart transplantpediatric kidney transplant recipients

Phase 2

Interest of belatacept as a non-nephrotoxic immunosuppressive treatment in cardiac transplant patients at risk of chronic renal failure.

Not yet recruitingCTIS2024-516541-40-00

Centre Hospitalier Universitaire De NantesEarly graft dysfunction after heart transplant

Target: 25Updated: 2026-01-07

Phase 4

Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulation

Not yet recruitingCTIS2024-511585-36-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)pediatric kidney transplant recipients

Target: 28Updated: 2024-06-28